Risk Stratification According to Baseline and Early Change in Neutrophil-to-Lymphocyte Ratio in Advanced Non-Small Cell Lung Cancer Treated with Chemoimmunotherapy: A Multicenter Real-World Study-Reference-Cited by-同舟云学术

Risk Stratification According to Baseline and Early Change in Neutrophil-to-Lymphocyte Ratio in Advanced Non-Small Cell Lung Cancer Treated with Chemoimmunotherapy: A Multicenter Real-World Study

Published:2024-07-11 Issue:5 Volume:19 Page:757-767
ISSN:1776-2596
Container-title:Targeted Oncology
language:en
Short-container-title:Targ Oncol

Author:

Matsumoto Kinnosuke,Yamamoto Yuji,Shiroyama Takayuki,Kuge Tomoki,Mori Masahide,Tamiya Motohiro,Kinehara Yuhei,Tamiya Akihiro,Suzuki Hidekazu,Tobita Satoshi,Ueno Kiyonobu,Niki Toshie,Nagatomo Izumi,Takeda Yoshito,Kumanogoh Atsushi

Funder

Japan Society for the Promotion of Science

Open Access funding provided by Osaka University.

Osaka University

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s11523-024-01084-7.pdf

Reference39 articles.

1. Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics, 2023. CA Cancer J Clin. 2023;73:17–48. https://doi.org/10.3322/caac.21763.

2. Molina JR, Yang P, Cassivi SD, Schild SE, Adjei AA. Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship. Mayo Clin Proc. 2008;83:584–94. https://doi.org/10.4065/83.5.584.

3. Kunimasa K, Matsumoto S, Kawamura T, Inoue T, Tamiya M, Kanzaki R, et al. Clinical application of the AMOY 9-in-1 panel to lung cancer patients. Lung Cancer. 2023;179:107190. https://doi.org/10.1016/j.lungcan.2023.107190.

4. Gandhi L, Rodríguez-Abreu D, Gadgeel S, Esteban E, Felip E, De Angelis F, Domine M, et al. Pembrolizumab plus chemotherapy in metastatic non-small-cell lung cancer. N Engl J Med. 2018;378:2078–92. https://doi.org/10.1056/NEJMoa1801005.

5. Paz-Ares L, Luft A, Vicente D, Tafreshi A, Gümüş M, Mazières J, et al. Pembrolizumab plus chemotherapy for squamous non-small-cell lung cancer. N Engl J Med. 2018;379:2040–51. https://doi.org/10.1056/NEJMoa1810865.